Amidst ongoing efforts to combat COVID-19, Guyana has recorded 371 new positive cases since the beginning of 2024, reaffirming the persistent challenges faced by the Ministry of Health. The current variant circulating in the country has been identified as JN1, a release from the ministry said.
It added that in the ongoing battle against COVID-19, vaccination remains a cornerstone of defence. In February, the US government donated 1,000 doses of Paxlovid, a drug used to treat COVID-19, to Guyana. The medication complements a separate donation of 354,660 Pfizer vaccine doses. Paxlovid, an antiviral medication, functions by halting the replication and dissemination of the virus responsible for COVID-19 in the body.
